Funder
University of Texas MD Anderson Cancer Center
NIH
AbbVie
National Cancer Institute
GlaxoSmithKline
Reference92 articles.
1. A clinical, morphological and molecular study of 70 patients with gastrointestinal involvement in systemic mastocytosis;Lübke;Sci Rep,2024
2. Bose P, Masarova L, Amin HM, Verstovsek S Philadelphia Chromosome-Negative Myeloproliferative Neoplasms. In: Kantarjian HM, Wolff RA, Rieber AG, Eds., The MD Anderson Manual of Medical Oncology; 4th edition, McGraw Hill: China; pp 119-162.
3. Epidemiology of systemic mastocytosis in Denmark;Cohen;Br J Haematol,2014
4. Advanced systemic mastocytosis: the impact of KIT mutations in diagnosis, treatment, and progression;Verstovsek;Eur J Haematol,2013
5. KIT mutations and other genetic defects in mastocytosis;Chantran;Immunol Allergy Clin North Am,2023